Malaysia's Quiet Medical Tourism Boom, and the Agency Behind It

A Jakarta family flies in for a father’s heart bypass. A British couple books IVF because the wait list at home stretches past their fertility window. A Bangladeshi patient comes for a routine health screen his hometown clinic cannot run.

None of them are unusual. In 2024, Malaysia welcomed roughly 1.6 million healthcare travellers who generated an estimated RM2.72 billion in revenue — up 14% and 21% respectively on the year before. By 2025 the Malaysia Healthcare Travel Council (MHTC) was reporting a record year, provisionally in the region of RM3.3–3.4 billion, ahead of its RM3 billion target and on track toward a stated RM12 billion goal by 2030.

Most explainers on this topic stop at “top hospitals” and price lists. The more useful question is different: what is actually pulling patients here, and what does MHTC — the agency whose name is attached to almost every article on the subject — really do?

The scale, in context

Metric	2024	2025 (provisional)
Healthcare travellers	~1.6 million	record year, above target
Revenue	RM2.72 billion	~RM3.3–3.4 billion
Year-on-year growth	+14% travellers, +21% revenue	surpassed RM3 billion target

MHTC works with a network of more than 80 member hospitals nationwide, coordinated under the “Malaysia Healthcare” brand. The council’s stated long-term ambition — RM12 billion in industry revenue by 2030 — is roughly four times where the industry sat in 2024, which gives a sense of how much runway the government thinks this sector still has.

Indonesia is consistently the largest single source market, a function of geography, cultural familiarity and decades of established patient-referral pathways, followed by China, India, Singapore and the United Kingdom.

What patients actually come for

Marketing pages for Malaysian hospitals list dozens of specialties. In practice, a smaller set of treatments dominates:

• Cardiology — cardiac surgery and interventional cardiology, anchored by specialist centres such as Institut Jantung Negara (the National Heart Institute)
• Fertility and IVF — a major draw for patients from countries where assisted reproduction is expensive, restricted, or has long public waiting lists
• Oncology — cancer diagnosis and treatment, often sought by regional patients weighing Malaysia against Singapore or Thailand
• Orthopaedics — joint replacement and sports medicine
• Health screening — executive check-ups bundled with a short trip, popular with regional business travellers
• Dental and cosmetic procedures — a high-volume, price-sensitive segment, especially from neighbouring countries

What unites this list is not exoticism — it is procedures that are either expensive, slow to access, or hard to get scheduled quickly in the patient’s home country.

Why Malaysia specifically

Three things recur in patient decision-making, and they are structural rather than marketing claims:

Accredited private capacity that runs in parallel to the public system. Malaysia’s private hospitals operate under Ministry of Health licensing, and many additionally hold accreditation from the Malaysian Society for Quality in Health (MSQH) — the national accreditation body — or from Joint Commission International (JCI), the international standard used across much of the medical tourism industry. That two-track accreditation (domestic MSQH plus international JCI) is one of the less-discussed reasons Malaysia is trusted by both regional and Western patients: it can point to a local quality system as well as a globally recognised one.

English-language medicine. Malaysian doctors are trained and examine in English, which removes a friction point that countries like Thailand and Turkey — Malaysia’s main regional competitors — have to solve with interpreters.

Lower cost relative to Singapore, Australia, the UK and the US for comparable private care. Exact prices vary by hospital, procedure complexity and surgeon, and change over time — so this article deliberately does not quote figures. The consistent, verifiable pattern across the industry’s own reporting is relative positioning: Malaysian private treatment is marketed and priced to undercut its immediate regional rival (Singapore) and developed-market alternatives, while remaining at accredited-hospital quality. Patients comparing options should always request a written quotation directly from the specific hospital before travelling.

What MHTC actually does — and doesn’t

This is where most coverage blurs the picture. MHTC is a government agency, established under the purview of the Ministry of Health, tasked with developing and promoting the “Malaysia Healthcare” brand and coordinating the industry’s growth.

Concretely, MHTC:

• Curates a network of member hospitals that meet its participation criteria
• Runs concierge services — helping foreign patients get appointments, navigate hospitals, and arrange practical support around a treatment trip
• Markets Malaysia internationally as a healthcare travel destination (campaigns such as Malaysia Year of Medical Tourism 2026, themed “Healing Meets Hospitality”)
• Publishes annual performance statistics for the industry
• Runs recognition programmes for member hospitals, such as its Flagship Medical Tourism Hospital award

MHTC does not:

• Treat patients — it has no clinical function
• Set, cap, or negotiate hospital prices
• License hospitals or register doctors — that sits with the Ministry of Health and the Malaysian Medical Council respectively
• Issue medical accreditation — MSQH and JCI do that, independently of MHTC

In short: MHTC is the front door and the promoter, not the regulator and not the provider. The regulatory backbone (licensing, doctor registration, quality accreditation) sits entirely outside it, with the Ministry of Health, the Malaysian Medical Council, MSQH and JCI each doing a distinct job.

Common mistakes

• Assuming MHTC accreditation is the same as hospital licensing. Being an MHTC member hospital is a marketing/coordination status, not a substitute for Ministry of Health licensing or MSQH/JCI clinical accreditation — check for the latter separately.
• Treating any single “average cost” figure online as reliable. Prices are hospital- and procedure-specific and change; only a written quotation from the treating hospital is a safe number to plan around.
• Assuming MHTC can resolve a billing or treatment dispute. As a promotional and coordinating body, MHTC is not positioned as a clinical complaints authority — disputes over care sit with the hospital, and regulatorily with the Ministry of Health.
• Confusing “medical tourism” with medical evacuation or emergency care. The industry MHTC describes is planned, elective travel for treatment, not emergency repatriation.

What’s next

Two related questions this article doesn’t answer in depth: how a foreign retiree living in Malaysia under MM2H accesses private healthcare day-to-day (a different question from a short medical-tourism trip), and how Malaysia’s private health insurance and takaful products treat non-citizens. Both sit closer to the “living here” side of healthcare than the “flying in for treatment” side covered above.